topSkip to main content

Menu, Secondary

Menu Trigger

Menu

National Institutes of Health

Biomedical research funded by the National Institutes of Health (NIH) and performed at research universities helps assure U.S. leadership in the life sciences revolution of the 21st Century. Putting NIH on a sustained pathway to restore its purchasing power after a decade worth of loss to inflation and budget cuts is critical to sustaining the extraordinary progress in the improvement of human health of the past decades. Investment in NIH will continue to create jobs and strengthen the workforce, improve the lives—and quality of life—of millions of current and future patients, and help assure continuing U.S. economic and national security.

Sustained investment in biotechnology and genomics is crucial to the development of novel therapies for diseases, including: cancer, Alzheimer's, autism, and diabetes. The NIH also responds rapidly to public health emergencies and in support of biodefense, such as in the case of Ebola, Zika, and influenza.

 

Thirty-one Nobel Laureates and Science Community Leaders including AAU President Mary Sue Coleman sent a letter to the President of the United States and Members of Congress to call attention to the harm done to American Science during the partial shutdown of the federal government.
The Association of American Universities (AAU), the Association of American Medical Colleges (AAMC), and the Association of Public and Land-grant Universities (APLU) wrote a letter to Congress in support of ethically-conducted research that includes the use of fetal tissue. 
The Association of American Medical Colleges, Association of American Universities, Association of Public and Land-grant Universities, and Council on Government Relations collectively wrote recommendations to the proposed changes to the NIH Guidelines for research involving Recombinant or Synthetic Nucleic Acid Molecules.
AAU President Mary Sue Coleman today wrote to House and Senate Appropriations leaders to applaud their efforts in securing increased higher education and research investments in FY19 and urge completion of the remaining FY19 appropriations bills after the midterm elections.
AAU and several other associations wrote to House leadership to urge passage of the FY19 Labor-HHS-Education and Defense spending bill. The letter says the associations are grateful for the “meaningful increases for the programs that make college accessible and promote medical research.”
AAU President Mary Sue Coleman sent a letter to House and Senate Appropriators urging them to adopt the Senate-passed funding levels for the National Institutes of Health (NIH) and for the maximum Pell Grant.
The Ad Hoc Group for Medical Research, of which AAU is a member, wrote to Congress recommending members appropriate $39.3 billion in FY 2019 for National Institutes of Health (NIH).
AAU urges Congress to provide at least $39.3 billion for the National Institutes of Health (NIH) in FY19.